Biomarin Pharmaceutical shares owned by Raab & Moskowitz Asset Management
Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Raab & Moskowitz Asset Management
from 13F filings
Historical chart of Raab & Moskowitz Asset Management investment in Biomarin Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Biomarin Pharmaceutical held by Raab & Moskowitz Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Biomarin Pharmaceutical by Raab & Moskowitz Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $29k | 30k | 0.95 |
2024-06-30 | $29k | 30k | 0.96 |
2024-03-31 | $30k | 30k | 0.99 |
2023-12-31 | $31k | 30k | 1.03 |
2023-09-30 | $30k | 30k | 0.99 |
2023-06-30 | $30k | 30k | 1.01 |
2023-03-31 | $31k | 30k | 1.04 |
2022-12-31 | $33k | 30k | 1.09 |
2022-09-30 | $30k | 30k | 1.00 |
2022-06-30 | $30k | 30k | 1.00 |
More positions owned by Raab & Moskowitz Asset Management
View all positions for Raab & Moskowitz Asset Management